Ϫ ) and nitric oxide (NO) interaction in mediating the renal actions of ANG II, we examined the renal responses to intra-arterial infusion of ANG II (0.5 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 ) before and during administration of a superoxide dismutase mimetic, tempol (0.5 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 ), in the presence or absence of NO synthase inhibitor, nitro-L-arginine (NLA; 50 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ), in anesthetized dogs pretreated with enalaprilat (33 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ). In one group of dogs (n ϭ 7), ANG II infusion before tempol infusion caused decreases of 24 Ϯ 4% in renal blood flow (RBF), 55 Ϯ 7% in urine flow (V), and 53 Ϯ 8% in urinary sodium excretion (UNaV) with a slight decrease in glomerular filtration rate (GFR; Ϫ7.8 Ϯ 3.4%). Tempol infusion alone did not cause significant alterations in RBF, GFR, V, or U NaV; however, ANG II in the presence of tempol caused a smaller degree of decreases in RBF (Ϫ12 Ϯ 2%), in V (Ϫ16 Ϯ 5%), and in UNaV (Ϫ27 Ϯ 10%) with a slight increase in GFR (6.6 Ϯ 2.8%) than the responses observed before tempol. In another group of NLA-treated dogs (n ϭ 6), tempol infusion also caused significant attenuation in the ANG II-induced responses on RBF (Ϫ13 Ϯ 3% vs. Ϫ22 Ϯ 7%), GFR (Ϫ19 Ϯ 5% vs. Ϫ33 Ϯ 3), V (Ϫ15 Ϯ 12% vs. Ϫ28 Ϯ 4%), and U NaV (Ϫ11 Ϯ 14% vs. Ϫ32 Ϯ 7%). These data demonstrate that renal responses to ANG II are partly mediated by O 2 Ϫ generation and its interaction with NO. The sodium-retaining effect of ANG II is greatly influenced by O 2 Ϫ generation, particularly in the condition of NO deficiency. renal hemodynamics; sodium excretion; tempol; nitro-L-arginine CELLULAR METABOLISM OF MOLECULAR oxygen results in the production of reactive oxygen species (ROS), such as superoxide anion (O 2 Ϫ ; see Ref. 6). An inappropriate generation of ROS is a feature of many disease processes, including high blood pressure-related vasculopathy or nephropathy (2, 32). The ROS generation in the kidney could play a critical role in the pathogenesis of hypertensive disease, since this contributes to many derangements in renal function (28, 32) . The link between ROS and the development of hypertension has been proposed, since it was observed that hypertensive patients possess higher levels of some ROS components and lower levels of the antioxidant vitamin C in the plasma compared with normotensive subjects (13). O 2 Ϫ , a common ROS component, has been shown to be associated with development of hypertension (13, 15, 37, 39) . Furthermore, administration of the superoxide dismutase (SOD) mimetic tempol (4-hydroxy 2,2,6,6,-tetramethyl piperidinoxyl) causes reductions in blood pressure in spontaneously hypertensive rats (SHR) and ANG II-induced hypertensive rats (25, 30, 31) .
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, a common ROS component, has been shown to be associated with development of hypertension (13, 15, 37, 39) . Furthermore, administration of the superoxide dismutase (SOD) mimetic tempol (4-hydroxy 2,2,6,6,-tetramethyl piperidinoxyl) causes reductions in blood pressure in spontaneously hypertensive rats (SHR) and ANG II-induced hypertensive rats (25, 30, 31) .
Although a role for O 2 Ϫ has been suggested in ANG IIinduced hypertension, it is not yet clear how much it can contribute to the acute vasoconstrictor or antinatriuretic effects of ANG II in the kidney. O 2 Ϫ has been implicated in various studies to be a potential mediator of ANG II-induced intracellular signaling pathways (7, 35) . It has been shown that both O 2 Ϫ and nitric oxide (NO) can be formed endogenously by the action of ANG II (12, 27, 33) . Recent studies have also implicated a potential interaction between O 2 Ϫ and NO in the regulation of renal vascular and tubular function (20, 39) . We have reported earlier that enhancement of O 2 Ϫ activity by the administration of an SOD inhibitor in the kidney results in vasoconstriction and sodium retention (20) . These renal effects of SOD inhibition were augmented during blockade of NO formation (20) . These findings indicate that O 2 Ϫ can exert direct vasoconstriction and tubular effects independently of its interaction with NO in the kidney. In a recent study in rats, renal effects of acute administration of ANG II have shown to be partially attenuated with a SOD mimetic or an inhibitor of NADPH oxidase (18) . Because O 2 Ϫ generation can also reduce NO bioavailability, it is possible that the acute actions of ANG II are modulated by O 2 Ϫ and NO interactions in the kidney. However, the possible impacts of this O 2 Ϫ -NO interaction on the renal vascular and tubular actions of ANG II are yet to be determined.
We hypothesized that the renal vasoconstrictor and antinatriuretic responses to ANG II are influenced by O 2 Ϫ generation and that NO plays a renoprotective role in balancing the adverse effects of O 2 Ϫ . To examine this hypothesis, the present investigation was designed to evaluate the role of O 2 Ϫ generation and its possible interaction with NO on ANG II-induced changes in renal hemodynamics and excretory function. Accordingly, renal responses to acute infusion of ANG II were evaluated before and during administration of a SOD mimetic, tempol, in anesthetized dogs pretreated with or without an NO synthase (NOS) inhibitor, nitro-L-arginine (NLA; see Refs. 19 -21) . All of these experiments in dogs were carried out during continuous infusion of the angiotensin-converting enzyme (ACE) inhibitor enalaprilat (33 g⅐kg Ϫ1 ⅐min Ϫ1 ; see Ref. 24) to minimize changes in endogenous levels of ANG II.
METHODS
These experiments were performed in accordance with the guidelines and practices established by the Tulane University Animal Care and Use Committee. Mongrel dogs of either gender (12-23 kg body wt; some of them were beagles) were used for these experiments. To achieve a sodium-replete state, these dogs were given a supplemental amount of sodium chloride (1.5 g ⅐ kg body wt Ϫ1 ⅐ day Ϫ1 ) added to the normal laboratory ration for 3 days (20, 21) . They were anesthetized with pentobarbital sodium (30 mg/kg iv), with additional amounts given as needed to maintain an appropriate level of anesthesia. The surgical preparation of the animals and basic experimental techniques are identical to those previously described (19 -21) . Briefly, a cuffed endotracheal tube was inserted in the trachea and connected to an artificial respirator, which was set at a rate of 18 strokes/min with a stroke volume of 15 ml/kg body wt. Body temperature was maintained at a near-constant level (ϳ100°F) with an electric heating pad. Systemic arterial pressure was measured from a catheter placed in the abdominal aorta inserted through the right femoral artery. The catheter was connected to a pressure transducer, and systemic arterial pressure was recorded on a polygraph (model 7D; Grass Instruments). The left femoral artery was cannulated for collection of blood samples. The femoral and jugular veins were cannulated for administration of saline, inulin solution, and additional doses of pentobarbital sodium, as necessary.
The left kidney was exposed through a flank incision, and the renal artery was isolated from surrounding tissue. All visible nerves projecting from the aorticoadrenal gland were cut to achieve denervation of the kidney. Renal blood flow (RBF) was measured with an electromagnetic flow probe placed on the renal artery near its origin from the aorta and connected to a square-wave flowmeter (Carolina Medical Electronics). A curved 23-gauge needle cannula was inserted in the renal artery distal to the flow probe and was connected to a pressure transducer for measurement of renal arterial pressure. Another catheter was also connected to this needle cannula for continuous infusion of heparinized saline or drug solutions at a rate of 0.4 ml/min.
The experiments were conducted in two groups of dogs that were given continuous infusion of enalaprilat (33 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ; see Ref. 24) . Enalaprilat is the active metabolite of the prodrug enalaprilat maleate. This is a rapidly acting drug when administered intravenously. It has been observed that intra-arterial administration of enalaprilat in anesthetized dogs shows its maximum effects on RBF within 10 min of administration (24) . In the first group (n ϭ 7), renal responses to infusion of ANG II (0.5 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 ) were evaluated before and during infusion of tempol (0.5 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 ). This dose of ANG II was chosen from preliminary experiments that showed an ϳ25% decrease in basal RBF. To assess the changes during interventions with other drugs, this range of vasoconstrictor responses to ANG II was considered reasonable. The dose of tempol was used previously in our laboratory and was shown to completely reduce the enhanced 8-isoprostane levels (marker for oxidative stress) during NOS inhibition in dogs (21) . Initially, we tested by infusing this dose of tempol intra-arterially in anesthetized dogs that showed a reduction of ϳ60% in urinary excretion rate of 8-isoprostane (U ISOV) during a 30-min infusion period (unpublished observation). Such reduction in 8-isoprostane excretion was similar to what was reported earlier in SHR with the use of a similar dose that was effective in normalizing the blood pressure in SHR (30, 31) . In the second group of dogs (n ϭ 6), renal responses to ANG II infusion were evaluated before and during NOS inhibition by NLA (50 g ⅐ kg Ϫ1 ⅐ min Ϫ1 ; see Refs. 19 -21) and then during combined infusion of NLA plus tempol.
Experimental protocols in group 1. After completion of surgery and a 45-min stabilization period, the experimental protocol began with two consecutive 10-min control urine collections with arterial blood samples (2 ml) collected at the midpoint of each collection period. Next, a continuous infusion of enalaprilat (24) was initiated intra-arterially for the whole duration of the experimental period. Thus, in the present protocol, the responses to enalaprilat were evaluated during two 10-min collection periods after a 10-min stabilization period. At the end of two 10-min collection periods, ANG II was added to the infusion line in which enalaprilat is continuously given throughout the whole protocol period. After 10 min of the initiation of ANG II infusion, two more 10-min urine samples were collected. Next, ANG II infusion was stopped, and 10 min were allowed for stabilization before collections of two more 10-min urine samples (control collections before tempol administration). Tempol was then added to the infusion line. After 10 min of tempol infusion, two 10-min urine collections were made. Then, ANG II infusion was added to the infusion line with tempol, and two more collections of urine were made after 10 min of the initiation of combined tempol plus NLA infusion. In three additional dogs, ANG II infusion was repeated with a gap period of 1 h without coadministration of tempol to examine the ANG II responsiveness resulting from its repeated administration (time control experiments).
Experimental protocols in group 2. The protocol began with two consecutive 10-min control collections, followed by a continuous intra-arterial infusion of enalaprilat (22) for the whole duration of the experimental period. After 10 min of the initiation of enalaprilat infusion, two additional 10-min urine samples were collected. Next, an intra-arterial infusion of ANG II was initiated, and renal clearances were evaluated as stated earlier in the group 1 protocol. After the cessation of ANG II infusion, an intra-arterial infusion of NLA was initiated and continued for the rest of the period. After 30 min of the initiation of NLA infusion, two 10-min urine collections were made (19, 20) . In all previous studies in dogs with NLA in our laboratory, a 30-min stabilization period was considered, as this period was seen sufficient to achieve a maximal effect of NLA on RBF. After collection of two 10-min urine samples during NLA infusion period, ANG II was added to the infusion line, and renal clearances were evaluated during ANG II infusion, as stated above. ANG II infusion was then stopped, and 10 min were allowed for recovery of the renal parameters. Next, tempol was added to the NLA infusion line (21). After 10 http://ajprenal.physiology.org/ min of the initiation of tempol infusion, two 10-min urine samples were collected. Thereafter, ANG II infusion was initiated in the presence of NLA plus tempol. After 10 min of stabilization, two 10-min urine collections were made during ANG II infusion. Sodium, potassium, and inulin concentrations in plasma and urine were determined as previously described (19 -21) . Urinary concentrations of 8-isoprostane and NO metabolites nitrate/nitrite were determined using an enzyme immunoassay kit (Assay Design; see Ref. 21) . Urinary concentration of H 2O2 was also measured with a H2O2 assay kit (Caymen Chemical). Because the measurement of urinary 8-isoprostane and H 2O2 was not considered in the initial design of the protocol for group 1 dogs, urine was not collected methodically and, thus, was not considered for analysis in group 1. Values are reported as means Ϯ SE. Statistical comparisons of differences in the responses were conducted with either ANOVA (in case of absolute changes) or Student's paired t-test (in case of percent changes). Differences in the mean values were deemed significant at P Յ 0.05.
RESULTS

Effects of tempol on renal responses to ANG II (group 1).
The summarized results obtained from seven dogs are shown in Table 1 . Intrarenal ACE inhibition with enalaprilat resulted in changes in RBF, renal vascular resistance (RVR), and other renal parameters, as reported earlier (19, 24) . It was noted that the enalaprilat treatment caused a small but significant (P Ͻ 0.05) increase in GFR in these dogs. ANG II infusion in enalaprilat-treated dogs caused increases in RVR (P Ͻ 0.05) and decreases (P Ͻ 0.05) in RBF, urine flow (V), and urinary sodium excretion (U Na V), with a minimal decrease in glomerular filtration rate (GFR). Table 1 provides the absolute values and Figs. 1-4 show both the absolute (A) and percent (B) changes in RBF, GFR, V, and U Na V responses, respectively, observed during ANG II infusion in these seven dogs. ANG II infusion in these anesthetized dog preparations caused increases in filtration fraction, as reported previously (29) . During tempol treatment, a similar increment in filtration fraction resulting from ANG II was also observed (Table 1) . After cessation of ANG II infusion for nearly 30 min, the RBF and excretory function showed a partial recovery of the control values before ANG II infusion; the reason for such incomplete recovery was not clear. In a few of these dogs, extension of the recovery period beyond 40 -50 min also did not restore these baselines completely. However, the administration of tempol in these enalaprilat-treated dogs did not cause any significant renal parameter changes (Table 1) . Interestingly, the renal vasoconstrictor and the antinatriuretic responses to ANG II were markedly attenuated during infusion of tempol. Urinary nitrate/nitrite excretion rate (U NOX V) increased significantly (P Ͻ 0.05) during enalaprilat treatment (Table 1) . U NOX V decreased significantly (P Ͻ 0.05) in response to ANG II before but not during tempol infusion (Table 1) .
Effects of tempol on renal responses to ANG II in NOSinhibited dogs (group 2).
The summarized results in absolute values obtained from six dogs are shown in Table 2 , and the changes (both absolute and percent) in the responses to ANG II are shown in Figs. 5-8. Intra-arterial infusion of the ACE inhibitor enalaprilat resulted in similar responses, as observed in the group 1 dogs. As reported previously (19 -21) , intraarterial infusion of NLA resulted in a significant (P Ͻ 0.05) increase in RVR and reductions in RBF, V, and U Na V without significant change in GFR. ANG II infusion in these dogs before NOS inhibition by NLA also resulted in similar responses, as in group 1. There were somewhat similar changes in RBF and in RVR due to ANG II infusion before and during NLA administration. However, ANG II caused a marked reduction (P Ͻ 0.001) in GFR during NLA infusion (Fig. 6) , as reported previously in conscious dogs (1) . ANG II infusion during NLA treatment showed decreases (P Ͻ 0.05) in V and U Na V (Figs. 6 and 7) but not in fractional excretion of sodium (FE Na ; Table 2 ), as this is influenced by the reduction in GFR. NLA infusion also caused increases in the filtration fraction but prevented ANG II-induced changes in filtration fraction (Table 2).
Tempol infusion in these NLA-treated dogs also did not cause significant changes in RBF, RVR, or GFR but resulted in significant (P Ͻ 0.05) increases in V, U Na V, and FE Na , as reported in our earlier study (21) . Similar to the group 1 experiments, the RBF response to ANG II was also significantly (P Ͻ 0.05) attenuated during tempol infusion in NLAtreated dogs (Fig. 5) . The ANG II-induced reduction in GFR during NLA infusion was significantly (P Ͻ 0.05) attenuated during coadministration of tempol (Fig. 6) . Interestingly, ANG II infusion failed to cause any significant changes in V, U Na V, or FE Na during combined infusion of tempol and NLA (Table  2 ; Figs. 7 and 8) .
U ISO V was significantly (P Ͻ 0.05) decreased by enalaprilat treatment. ANG II infusion in enalaprilat-treated dogs significantly (P Ͻ 0.05) increased U ISO V before NLA infusion. U ISO V remained higher during enalaprilat plus NLA infusion than during NLA alone and was lower during enalaprilat plus NLA plus tempol infusion. These findings are similar to the results reported in our previous study (21) . However, U ISO V did not increase in response to ANG II infusion during enalaprilat plus NLA or enalaprilat plus NLA plus tempol infusion. As seen in group 1 dogs, U NOX V was increased (P Ͻ 0.05) during the enalaprilat infusion period and decreased (P Ͻ 0.05) during ANG II infusion before infusion of NLA. As expected, NLA infusion decreased (P Ͻ 0.05) U NOX V compared with the values during enalaprilat treatment or the control period and did not change significantly during the combination of NLA and tempol infusion, as reported previously (21) . U NOX V did not change significantly in response to ANG II during NLA or NLA plus tempol infusion periods. The urinary excretion rate of H 2 O 2 (n ϭ 5) showed a wide variation among the dogs, and the changes in response to the administration of enalaprilat, ANG II, tempol, or NLA were not significantly different from each other. However, the values of urinary excretion of H 2 O 2 observed in the present study were within the range that was reported earlier in human urine (17) .
Time-dependent changes in the renal responses to ANG II during tempol/NLA administration. We compared the vasoconstrictor responses to ANG II infusions before and during tempol with or without NLA administration, and these responses were calculated by the changes observed due to ANG II infusion from the baseline values just before infusion. In time control experiments (n ϭ 3), ANG II infusions were repeated with a gap period of 1 h without coadministration of tempol. This interval period of 1 h was somewhat similar to the Values are means Ϯ SE; n ϭ 6 in each parameter except H2O2 excretion in which n ϭ 5. NLA, nitro-L-arginine. P Ͻ 0.05 vs. control value (*), vs. Enal values ( †), and vs. Enal ϩ NLA values ( ‡). §, 0.1 Ͼ P Ͼ 0.05 vs. Enal period. usually lapsed time between two infusions of ANG II before and during tempol administration. It was observed that renal responses to ANG II during the first administration (RBF Ϫ15.0 Ϯ 4.0%, RVR ϩ23.1 Ϯ 2.5%, and U Na V Ϫ43.4 Ϯ 7.9%) were not different from the responses during the second administration (RBF Ϫ15.1 Ϯ 3.2%, RVR ϩ23.4 Ϯ 3.4%, and U Na V Ϫ49.5 Ϯ 2.6%). It is to be noted here that our previous studies in dogs (19 -21) demonstrated the maximal effects of NLA within 30 min of infusion that remained unchanged for at least 2 h. Two infusions of ANG II before tempol administration in NOS-inhibited dogs were also made within 2 h of NLA administration. During long-term infusion of tempol in saltdepleted anesthetized dogs, we have also observed that renal responses to tempol reached their maximum within 10 -15 min of infusion and then remain unaltered during Ͼ60 min of the infusion period (unpublished observation). Thus the attenuation of renal responses to ANG II observed in the tempoltreated dogs before and during NOS inhibition was unlikely to be contributed by the time-dependent changes in these experiments.
DISCUSSION
In the present investigation, we have demonstrated that RBF and excretory responses to ANG II infusion are attenuated during intra-arterial infusion of a SOD mimetic, tempol, both in intact and in NOS-inhibited dogs. The marked reduction in GFR in response to ANG II, observed in NOS-inhibited dogs, was also considerably attenuated during tempol administration.
As a SOD mimetic agent, tempol effectively scavenges and chemically reduces the O 2 Ϫ radicals (23) . Thus the findings in the present investigation clearly indicate that O 2 Ϫ generation is partly involved in mediating renal responses to ANG II. Scavenging of O 2 Ϫ by tempol can attenuate the vasoconstrictor response to ANG II either by increasing NO bioavailability (5, 28, 39) and/or by reducing its direct vascular effects on intracellular calcium (34, 35) . Because tempol attenuates ANG II-induced vasoconstriction in NOS-inhibited dogs, it is conceivable that ANG II-induced O 2 Ϫ generation also exerts its direct effects on the renal vasculature. Such direct effects of O 2 Ϫ were also evident in our earlier study (20) that showed an enhancement of the renal vasoconstrictor response to SOD inhibition in NOS-inhibited dogs. However, the possibility of an incomplete blockade of NO formation in the renal vessels with the dose of NLA used in the present study could not be ruled out, since we have not made any direct measurement of renal content of NO in these experiments. However, functional evidence from our initial experiments (19) enhance, not attenuate, the renal actions of ANG II. Although tempol infusion was shown to cause a mild increase in H 2 O 2 level in the rat renal tissue (4), the present experiments in dogs demonstrate that the urinary excretion rate of H 2 O 2 was not increased by tempol infusion. It was also reported earlier that tempol administration did not alter the tissue H 2 O 2 level in vitro (10) .
The involvement of O 2 Ϫ in the renal vascular responses to ANG II demonstrated in the present study are in agreement with the results of another study conducted in our laboratory (11) in which the renal vasoconstrictor response to ANG II administration was shown to be comparatively less in mice lacking the gp91 phox subunit of NADPH oxidase (an enzyme necessary for ANG II-induced O 2 Ϫ production) than in wildtype mice. Renal vasoconstrictor response to ANG II infusion in rats was also attenuated during tempol infusion and by the NADPH oxidase inhibitor apocynin (18) . In humans, forearm blood flow responses to ANG II injection were attenuated during vitamin C administration (5) . Collectively, these findings indicate that the vasoconstrictor action of ANG II is partly mediated by the generation of O 2 Ϫ . It was shown in an in vitro study in isolated rat kidney (8) that ANG II administration facilitates the autoregulatory response through increased O 2 Ϫ formation mediated via ANG II type 1 receptors. Although previous studies in dogs provided no evidence for significant involvement of NO in the maintenance of normal autoregulatory behavior of RBF (19) , the results from some recent in vivo studies, particularly in rats, showed that acute inhibition of NOS resulted in autoregulatory resetting of RBF (14) and also showed improvement of impaired autoregulation in some models of hypertensive rats (36, 38) . Considering these facts, it is conceivable that such improvement of autoregulatory behavior during NOS inhibition could be the result of possible enhancement of O 2 Ϫ activity (8, 21) and thus suggest an important interactive role of O 2 Ϫ and NO in the control of renal function during an elevated condition of the renin-angiotensin system. It may also be argued that variations in prostaglandin synthesis may be involved in these responses to ANG II during NLA or tempol administration, since an interaction between cyclooxygenase and the renin-angiotensin-aldosterone system is also known to play a role in the regulation of kidney function (28) . In the present study, we have not measured any possible changes in intrarenal prostaglandin synthesis in response to ANG II infusion. However, we have plans to examine these interactions further in our future studies using inhibitors of prostaglandin synthesis.
Similar to the findings in a study conducted earlier in conscious dogs (1), the present study showed that ANG II caused a marked decrease in GFR during NOS inhibition. However, we have further observed that this ANG II-induced marked reduction in GFR in NLA-treated dogs was significantly attenuated during tempol infusion (Fig. 6) . The slight decrease in GFR resulting from ANG II in intact dogs was also abolished during tempol administration (Fig. 2) . These results show that O 2 Ϫ production contributes to the GFR responses to ANG II. Previous studies (8, 11, 39 ) also supported an inter- Ϫ and NO in regulating TGF-mediated changes in afferent arteriolar tone in SHR, a model known to have enhanced oxidative stress (30) . We have also reported (11) that ANG II administration caused no change in GFR in wild-type mice but caused an increase in GFR in knock-out (KO) mice lacking the gp91 phox subunit of NAD(P)H oxidase. This finding in our mice study (11) indicates that a lack of O 2 Ϫ production in response to ANG II in KO mice exerted proportionately less constrictor action on the afferent than on the efferent arterioles, resulting in an increase in glomerular pressure, thus leading to an increase in GFR. The results in the investigation also suggest that vasoconstrictor action of O 2 Ϫ in the afferent arteriole during ANG II infusion was mostly counteracted by NO in the intact state but unopposed in the state of NOS inhibition, thus causing a marked reduction in GFR. It is interesting to note that tempol treatment in both intact and NO-blocked dogs caused improvement in GFR, indicating that O 2 Ϫ may predominantly affect the preglomerular vascular resistance (8, 11, 39) . However, our present in vivo experiments do not allow us to comment on the relative contribution of afferent and efferent arteriolar resistances affected by O 2 Ϫ formation. Moreover, a prediction of alterations in segmental vascular resistance based on the changes in filtration fraction was also seriously questioned in a previous study using a computer-simulated experimental model of combined afferent and efferent resistance changes (3) .
As observed in our earlier study (21) , tempol administration in the present study did not cause any appreciable changes in RBF, V, and U Na V before NOS inhibition (Tables 1 and 2 ). However, tempol infusion during NLA administration resulted in increases in V and U Na V (Table 2 ) without appreciable changes in renal hemodynamics, as previously reported (21) . In the condition of NOS inhibition, tempol administration is not expected to cause an increase in RBF, since the vasodilator effect of scavenging O 2 Ϫ is primarily the result of the action of increased NO bioavailability in the vessel (21) . The present findings further support our earlier contention (21) that the basal O 2 Ϫ activity remained at a minimal level in normal conditions because of antioxidative effects of endogenous NO. During tempol administration, ANG II induced reduction in V and in U Na V was attenuated in both intact and NOS-inhibited dogs. There were no changes in FE Na in response to ANG II during tempol administration in NLA-treated dogs. Such marked attenuation of the renal excretory responses to ANG II during tempol infusion provides evidence in support of the involvement of O 2 Ϫ in ANG II-induced changes in tubular reabsorptive function. Results in NOS-inhibited dogs strongly suggest that ANG II-induced O 2 Ϫ production can affect tubular reabsorptive function independent of its effects on NO metabolism. These findings suggest that the renal excretory responses to ANG II are, at least in part, attributed to the tubular effects of O 2 Ϫ that are aggravated in the condition of NO deficiency. These results are in agreement with the reported in vitro study (26) in which O 2 Ϫ was shown to enhance renal tubular sodium transport in the thick ascending limb of the loop of Henle.
In these experiments in dogs, we have observed that ANG II infusion increased U ISO V and decreased U NOX V (Tables 1 and  2 ), as reported in other studies in rats (18) . These effects of ANG II on U ISO V and U NOX V were abolished during tempol and NLA infusion (Tables 1 and 2 ). Although an increase in U ISO V during ANG II is expected, the reason for a decrease in U NOX V in response to ANG II is not yet clear. However, although no direct evidence is currently available, one explanation could be that increases in O 2 Ϫ production during ANG II administration interacted with NO, and this chemical reaction between O 2 Ϫ and NO could reduce the formation of nitrite/ nitrites. As expected, U NOX V was decreased significantly during NLA infusion in these enalaprilat-treated dogs compared with values observed during enalaprilat infusion alone. U ISO V level was also higher during NLA infusion compared with values with enalaprilat alone, further supporting our earlier observation (21) that O 2 Ϫ levels in the kidney are enhanced during NOS inhibition. It has been observed that ACE inhibition decreases U ISO V and increases U NOX V (Tables 1 and 2 ). These findings are expected, since ACE inhibition decreased endogenous formation of ANG II that could cause a decrease in endogenous formation of O 2 Ϫ radical that is reflected in U ISO V. Reduced O 2 Ϫ formation thus leads to increases in endogenous NO bioavailability that have been reflected in increases in U NOX V.
Our study was not designed to define the source of O 2 Ϫ generation in the kidney during ANG II infusion. However, ANG II has been shown to stimulate O 2 Ϫ generation in the vascular smooth muscle (27) and mesangial cells (12) . The key enzyme systems involved in the ANG II-induced production of O 2 Ϫ are considered to be NADH and NADPH oxidase enzymes (27) . It has also been demonstrated that the thick ascending limbs of the loop of Henle are the major site for NADH oxidase enzyme, which could enhance production of O 2 Ϫ due to the action of ANG II (16) . Thus it is possible that O 2 Ϫ generation via NAD(P)H oxidase enzyme activation is involved in mediating renal actions of acute ANG II infusion in the present study.
The findings in the present investigation indicate that ANG II caused an enhanced production of O 2 Ϫ that alters renal hemodynamics and enhances tubular retention of salt and water, which could be involved in the development of hypertension during chronic administration of a subpressor dose of ANG II (28) . It was reported that chronic infusion of low doses of ANG II is accompanied by the stimulation of oxidative stress, as measured by a significant increase in plasma 8-isoprostane levels (9) . Although oxidative stress has been proposed to play a role in the development of ANG II-dependent hypertension, the exact mechanism involved in this pathophysiology is not yet clearly defined. The findings in the present study emphasize that the elucidation of complete interactions between ANG II, O 2 Ϫ , and NO is essential to further understand the renal mechanisms that are involved in the pathophysiology of ANG II-dependent hypertension.
In conclusion, the results of the present investigation demonstrate that the renal responses to ANG II are partly mediated by the generation of O 2 Ϫ and its interaction with NO. These findings further indicate that, in the condition of NO defi- 
